The Board remands the matter to obtain an adequate examination that clarifies whether high dose corticosteroids or immuno-suppressive medications are required for the Veteran's asthma, as well as to address other inconsistencies in the medical evidence.
The deciding factor: The January 2020 VA examination was found inadequate due to a lack of clarity regarding the use of high dose corticosteroids and immuno-suppressive medications, which is necessary for rating purposes.
- Claimed conditions
- asthma with obstructive sleep apnea (OSA)
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- February 27, 2025
- Citation
- A25018132
Veterans Law Judge
Decisions by this judge: 785 · Granted: 47% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A25018132.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Veteran's hypertension and asthma with obstructive sleep apnea (OSA) have been granted service connection, with the hypertension receiving a 20% rating effective October 18, 2023, and the asthma with OSA receiving a 100% rating effective August 18, 2025.
- Partly granted
The Board granted service connection for hypertension as secondary to the Veteran's service-connected OSA, restored a 60 percent rating for asthma with obstructive sleep apnea, and granted a 20 percent rating for dry eye syndrome during the period on appeal from September 17, 2023, to October 11, 2024. The Board denied a higher rating for unspecified depressive disorder.
- Partly granted
The Board granted service connection for a right knee disability and bilateral onychomycosis, as secondary to bilateral tinea pedis, while denying or remanding the other issues.
- Partly granted
The Board granted an initial 50 percent evaluation for migraine headaches, denied a higher rating for asthma with obstructive sleep apnea from August 15, 2023, and granted a 30 percent evaluation for asthma effective August 15, 2022.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.